 |
|
|
|
 |
|
|
|
|
|
|
Department
|
Cardiology
|
|
Hospital Title
|
Senior Associate
|
|
Academic Title
|
Associate Professor
|
|
Phone
|
617-355-7275
|
|
Fax
|
617-739-3784
|
|
Email
|
Kathy Jenkins
|
|
Location
|
300 Longwood Avenue
Farley-2
Boston MA 02115
|
 |
 |
|
|
|
|
|
|
|
|
Kathy Jenkins oversees the clinical trials of new devices, such as CardioSEAL and STARFlex, which are implanted by catheter to correct atrial septal defect, ventral septal defect, fontan fenestration, patent ductus arteriosis, and other congenital malformations of the heart. She works closely with the interventional cardiologists, institutional review board, device manufacturers, and FDA to ensure the trials are conducted properly.
|
|
|
|
|
|
Kathy Jenkins received her MD from Harvard Medical School and her MPH from Harvard School of Public Health. She completed an internship, residency and fellowship at Children's Hospital Boston.
|
|
|
|
|
- Perry YY, Triedman JK, Gauvreau K, Lock JE, Jenkins KJ. Sudden death in patients after transcatheter device implantation for congenital heart disease. American Journal of Cardiology 2000; 85: 992-995.
- Kreutzer J, Ryan CA, Wright JA, Jr., Jenkins KJ, Marx G, Van Praagh R, Lock JE. Acute animal studies of the STARFlex system: a new self-centering cardioSEAL septal occluder. Catheterization & Cardiovascular Interventions 2000; 49: 225-233.
- Boethig D, Jenkins KJ, Hecker H, Thies WR, Breymann T. The RACHS-1 risk categories reflect mortality and length of hospital stay in a large German pediatric cardiac surgery population. European Journal of Cardio-Thorac Surg 2004; 26: 12-17
|
|
|
|
|
|
|
|
|
|
|
